Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations (original) (raw)

Abstract

Pancreatic beta-cell function was studied in six subjects with mutations in the enzyme glucokinase (GCK) who were found to have elevated fasting and postprandial glucose levels in comparison to six normoglycemic controls. Insulin secretion rates (ISRs) were estimated by deconvolution of peripheral C-peptide values using a two-compartment model and individual C-peptide kinetics obtained after bolus intravenous injections of biosynthetic human C-peptide. First-phase insulin secretory responses to intravenous glucose and insulin secretion rates over a 24-h period on a weight maintenance diet were not different in subjects with GCK mutations and controls. However, the dose-response curve relating glucose and ISR obtained during graded intravenous glucose infusions was shifted to the right in the subjects with GCK mutations and average ISRs over a glucose range between 5 and 9 mM were 61% lower than those in controls. In the controls, the beta cell was most sensitive to an increase in glucose at concentrations between 5.5 and 6.0 mM, whereas in the patients with GCK mutations the point of maximal responsiveness was increased to between 6.5 and 7.5 mM. Even mutations that resulted in mild impairment of in vitro enzyme activity were associated with a > 50% reduction in ISR. The responsiveness of the beta cell to glucose was increased by 45% in the subjects with mutations after a 42-h intravenous glucose infusion at a rate of 4-6 mg/kg per min. During oscillatory glucose infusion with a period of 144 min, profiles from the subjects with mutations revealed reduced spectral power at 144 min for glucose and ISR compared with controls, indicating decreased ability to entrain the beta cell with exogenous glucose. In conclusion, subjects with mutations in GCK demonstrate decreased responsiveness of the beta cell to glucose manifest by a shift in the glucose ISR dose-response curve to the right and reduced ability to entrain the ultradian oscillations of insulin secretion with exogenous glucose. These results support a key role for the enzyme GCK in determining the in vivo glucose/ISR dose-response relationships and define the alterations in beta-cell responsiveness that occur in subjects with GCK mutations.

1120

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bedoya F. J., Matschinsky F. M., Shimizu T., O'Neil J. J., Appel M. C. Differential regulation of glucokinase activity in pancreatic islets and liver of the rat. J Biol Chem. 1986 Aug 15;261(23):10760–10764. [PubMed] [Google Scholar]
  2. Bell G. I., Xiang K. S., Newman M. V., Wu S. H., Wright L. G., Fajans S. S., Spielman R. S., Cox N. J. Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1484–1488. doi: 10.1073/pnas.88.4.1484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brelje T. C., Sorenson R. L. Nutrient and hormonal regulation of the threshold of glucose-stimulated insulin secretion in isolated rat pancreases. Endocrinology. 1988 Sep;123(3):1582–1590. doi: 10.1210/endo-123-3-1582. [DOI] [PubMed] [Google Scholar]
  4. DeFronzo R. A., Bonadonna R. C., Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 1992 Mar;15(3):318–368. doi: 10.2337/diacare.15.3.318. [DOI] [PubMed] [Google Scholar]
  5. Eaton R. P., Allen R. C., Schade D. S., Erickson K. M., Standefer J. Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. J Clin Endocrinol Metab. 1980 Sep;51(3):520–528. doi: 10.1210/jcem-51-3-520. [DOI] [PubMed] [Google Scholar]
  6. Faber O. K., Binder C., Markussen J., Heding L. G., Naithani V. K., Kuzuya H., Blix P., Horwitz D. L., Rubenstein A. H. Characterization of seven C-peptide antisera. Diabetes. 1978;27 (Suppl 1):170–177. doi: 10.2337/diab.27.1.s170. [DOI] [PubMed] [Google Scholar]
  7. Fajans S. S. Scope and heterogeneous nature of MODY. Diabetes Care. 1990 Jan;13(1):49–64. doi: 10.2337/diacare.13.1.49. [DOI] [PubMed] [Google Scholar]
  8. Froguel P., Vaxillaire M., Sun F., Velho G., Zouali H., Butel M. O., Lesage S., Vionnet N., Clément K., Fougerousse F. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature. 1992 Mar 12;356(6365):162–164. doi: 10.1038/356162a0. [DOI] [PubMed] [Google Scholar]
  9. Froguel P., Zouali H., Vionnet N., Velho G., Vaxillaire M., Sun F., Lesage S., Stoffel M., Takeda J., Passa P. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med. 1993 Mar 11;328(10):697–702. doi: 10.1056/NEJM199303113281005. [DOI] [PubMed] [Google Scholar]
  10. Gidh-Jain M., Takeda J., Xu L. Z., Lange A. J., Vionnet N., Stoffel M., Froguel P., Velho G., Sun F., Cohen D. Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1932–1936. doi: 10.1073/pnas.90.5.1932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Halter J. B., Graf R. J., Porte D., Jr Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycemia in diabetes compensates for imparied glucose potentiation. J Clin Endocrinol Metab. 1979 Jun;48(6):946–954. doi: 10.1210/jcem-48-6-946. [DOI] [PubMed] [Google Scholar]
  12. Hattersley A. T., Turner R. C., Permutt M. A., Patel P., Tanizawa Y., Chiu K. C., O'Rahilly S., Watkins P. J., Wainscoat J. S. Linkage of type 2 diabetes to the glucokinase gene. Lancet. 1992 May 30;339(8805):1307–1310. doi: 10.1016/0140-6736(92)91958-b. [DOI] [PubMed] [Google Scholar]
  13. Leahy J. L., Bonner-Weir S., Weir G. C. Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care. 1992 Mar;15(3):442–455. doi: 10.2337/diacare.15.3.442. [DOI] [PubMed] [Google Scholar]
  14. Levin S. R., Grodsky G. M., Hagura R., Smith D. F., Forsham P. H. Relationships between arginine and glucose in the induction of insulin secretion from the isolated, perfused rat pancreas. Endocrinology. 1972 Mar;90(3):624–631. doi: 10.1210/endo-90-3-624. [DOI] [PubMed] [Google Scholar]
  15. Levin S. R., Karam J. H., Hane S., Grodsky G. M., Forsham P. H. Enhancement of arginine-induced insulin secretion in man by prior administration of glucose. Diabetes. 1971 Mar;20(3):171–176. doi: 10.2337/diab.20.3.171. [DOI] [PubMed] [Google Scholar]
  16. Liang Y., Najafi H., Smith R. M., Zimmerman E. C., Magnuson M. A., Tal M., Matschinsky F. M. Concordant glucose induction of glucokinase, glucose usage, and glucose-stimulated insulin release in pancreatic islets maintained in organ culture. Diabetes. 1992 Jul;41(7):792–806. doi: 10.2337/diab.41.7.792. [DOI] [PubMed] [Google Scholar]
  17. Marynissen G., Leclercq-Meyer V., Sener A., Malaisse W. J. Perturbation of pancreatic islet function in glucose-infused rats. Metabolism. 1990 Jan;39(1):87–95. doi: 10.1016/0026-0495(90)90153-4. [DOI] [PubMed] [Google Scholar]
  18. Matschinsky F. M. Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes. Diabetes. 1990 Jun;39(6):647–652. doi: 10.2337/diab.39.6.647. [DOI] [PubMed] [Google Scholar]
  19. Matthews D. R., Hosker J. P., Rudenski A. S., Naylor B. A., Treacher D. F., Turner R. C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985 Jul;28(7):412–419. doi: 10.1007/BF00280883. [DOI] [PubMed] [Google Scholar]
  20. Meglasson M. D., Matschinsky F. M. Pancreatic islet glucose metabolism and regulation of insulin secretion. Diabetes Metab Rev. 1986;2(3-4):163–214. doi: 10.1002/dmr.5610020301. [DOI] [PubMed] [Google Scholar]
  21. O'Meara N. M., Sturis J., Van Cauter E., Polonsky K. S. Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus. J Clin Invest. 1993 Jul;92(1):262–271. doi: 10.1172/JCI116560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Polonsky K. S., Given B. D., Hirsch L. J., Tillil H., Shapiro E. T., Beebe C., Frank B. H., Galloway J. A., Van Cauter E. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med. 1988 May 12;318(19):1231–1239. doi: 10.1056/NEJM198805123181903. [DOI] [PubMed] [Google Scholar]
  23. Polonsky K. S., Licinio-Paixao J., Given B. D., Pugh W., Rue P., Galloway J., Karrison T., Frank B. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest. 1986 Jan;77(1):98–105. doi: 10.1172/JCI112308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Prager R., Wallace P., Olefsky J. M. In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. J Clin Invest. 1986 Aug;78(2):472–481. doi: 10.1172/JCI112599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Stoffel M., Froguel P., Takeda J., Zouali H., Vionnet N., Nishi S., Weber I. T., Harrison R. W., Pilkis S. J., Lesage S. Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7698–7702. doi: 10.1073/pnas.89.16.7698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sturis J., O'Meara N. M., Shapiro E. T., Blackman J. D., Tillil H., Polonsky K. S., Van Cauter E. Differential effects of glucose stimulation upon rapid pulses and ultradian oscillations of insulin secretion. J Clin Endocrinol Metab. 1993 Apr;76(4):895–901. doi: 10.1210/jcem.76.4.8473402. [DOI] [PubMed] [Google Scholar]
  27. Tchobroutsky G. Blood glucose levels in diabetic and non-diabetic subjects. Diabetologia. 1991 Feb;34(2):67–73. doi: 10.1007/BF00500374. [DOI] [PubMed] [Google Scholar]
  28. Timmers K. I., Powell A. M., Voyles N. R., Solomon D., Wilkins S. D., Bhathena S., Recant L. Multiple alterations in insulin responses to glucose in islets from 48-h glucose-infused nondiabetic rats. Diabetes. 1990 Nov;39(11):1436–1444. doi: 10.2337/diab.39.11.1436. [DOI] [PubMed] [Google Scholar]
  29. Van Cauter E. Estimating false-positive and false-negative errors in analyses of hormonal pulsatility. Am J Physiol. 1988 Jun;254(6 Pt 1):E786–E794. doi: 10.1152/ajpendo.1988.254.6.E786. [DOI] [PubMed] [Google Scholar]
  30. Velho G., Froguel P., Clement K., Pueyo M. E., Rakotoambinina B., Zouali H., Passa P., Cohen D., Robert J. J. Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. Lancet. 1992 Aug 22;340(8817):444–448. doi: 10.1016/0140-6736(92)91768-4. [DOI] [PubMed] [Google Scholar]
  31. Vionnet N., Stoffel M., Takeda J., Yasuda K., Bell G. I., Zouali H., Lesage S., Velho G., Iris F., Passa P. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature. 1992 Apr 23;356(6371):721–722. doi: 10.1038/356721a0. [DOI] [PubMed] [Google Scholar]
  32. Ward W. K., Halter J. B., Beard J. C., Porte D., Jr Adaptation of B and A cell function during prolonged glucose infusion in human subjects. Am J Physiol. 1984 May;246(5 Pt 1):E405–E411. doi: 10.1152/ajpendo.1984.246.5.E405. [DOI] [PubMed] [Google Scholar]
  33. Ward W. K., Wallum B. J., Beard J. C., Taborsky G. J., Jr, Porte D., Jr Reduction of glycemic potentiation. Sensitive indicator of beta-cell loss in partially pancreatectomized dogs. Diabetes. 1988 Jun;37(6):723–729. doi: 10.2337/diab.37.6.723. [DOI] [PubMed] [Google Scholar]
  34. Weir G. C. A defective beta-cell glucose sensor as a cause of diabetes. N Engl J Med. 1993 Mar 11;328(10):729–731. doi: 10.1056/NEJM199303113281012. [DOI] [PubMed] [Google Scholar]
  35. van Haeften T. W., Voetberg G. A., Gerich J. E., van der Veen E. A. Dose-response characteristics for arginine-stimulated insulin secretion in man and influence of hyperglycemia. J Clin Endocrinol Metab. 1989 Nov;69(5):1059–1064. doi: 10.1210/jcem-69-5-1059. [DOI] [PubMed] [Google Scholar]